The Mets are playing the Red Sox without Bo Bichette for a second consecutive day, and manager Andy Green didn't offer much optimism about a quick return. Leg soreness and a right ankle issue are keeping the infielder out, and Green's pre-game comment Saturday that Bichette may sit through the entire All-Star break tells you this isn't a game-time-decision situation. This is a known subtraction for however many games remain before the break.
What Bichette's Absence Actually Costs New York
Bichette is an everyday infielder whose value is tied to both his bat and his lineup-stabilizing presence in the middle of the order. The Mets losing him for two straight games, and potentially through the break, means someone is stepping into that spot against Boston's pitching. That matters on the run-line and in total discussions, because lineup depth changes how both managers construct matchups and how bullpens get deployed late.
For the Mets' series against the Red Sox, the immediate questions are straightforward: does New York's run-scoring potential drop enough to shade the total, and does it widen any spread if Boston is a starter-driven favorite? Without knowing the exact current lines on this game from the board, the directional pressure is clear: Bichette missing from the lineup is a mild but real negative for the Mets' offensive side. Teams absorb one missed infielder, but two days in a row from the same guy, with the manager flagging a multi-day absence, compounds the impact.
The All-Star Break Factor
Here's the part of this story that most bettors will underweight: Green saying Bichette might not play until after the break effectively removes him from any remaining pre-break schedule. That means he isn't a game-time-decision pop that moves lines on the morning of the next game. The uncertainty is already resolved. The market should be pricing this as a confirmed absence, not a question mark.
Post-break, Bichette returning healthy would be a positive for Mets futures and any team totals early in the second half. If the soreness lingers or he requires a stint on the injured list, that changes the calculus for New York's second-half outlook more meaningfully.
What I'm Watching Next
The injury list is the first confirmation point. If the Mets move Bichette to the 10-day IL before or just after the break, that's a clean signal his return timeline is longer than the current "rest through the break" framing implies. An IL move would apply pressure to Mets win-total futures, which are worth checking against the current pace with a confirmed multi-week hole at that infield spot.
I'm also watching whether Green gives any more specific return language in the next pre-game availability. "May sit through the break" is softer than "will sit through the break." If that language firms up, or if he appears in workouts before the break ends, that would update the futures read in either direction.
